tiprankstipranks
Trending News
More News >
The United Laboratories International Holdings Limited (ULIHF)
OTHER OTC:ULIHF
US Market

The United Laboratories International Holdings (ULIHF) Stock Forecast & Price Target

Compare
20 Followers
See the Price Targets and Ratings of:

ULIHF Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
The
United Laboratories International Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ULIHF Stock 12 Month Forecast

There Are No Analyst Ratings for ULIHF In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ULIHF Financial Forecast

ULIHF Earnings Forecast

Next quarter’s earnings estimate for ULIHF is $0.03 with a range of $0.03 to $0.03. The previous quarter’s EPS was $0.15. ULIHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ULIHF has Performed in-line its overall industry.
Next quarter’s earnings estimate for ULIHF is $0.03 with a range of $0.03 to $0.03. The previous quarter’s EPS was $0.15. ULIHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ULIHF has Performed in-line its overall industry.

ULIHF Sales Forecast

Next quarter’s sales forecast for ULIHF is $793.18M with a range of $793.18M to $793.18M. The previous quarter’s sales results were $1.03B. ULIHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ULIHF has Performed in-line its overall industry.
Next quarter’s sales forecast for ULIHF is $793.18M with a range of $793.18M to $793.18M. The previous quarter’s sales results were $1.03B. ULIHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ULIHF has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
First Shanghai Securities Analyst forecast on ULIHF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$2.28
Buy
21.15%
Upside
Reiterated
11/10/25
The United Laboratories International Holdings (ULIHF) Gets a Buy from First Shanghai Securities
Morgan Stanley Analyst forecast on ULIHF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$1.7
Hold
-9.48%
Downside
Reiterated
09/19/25
Huatai Securities Analyst forecast on ULIHF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$2.85
Buy
51.51%
Upside
Reiterated
09/06/25
Jefferies Analyst forecast on ULIHF
Jefferies
Jefferies
$2.18$2.56
Buy
36.13%
Upside
Reiterated
09/05/25
Jefferies Remains a Buy on The United Laboratories International Holdings (ULIHF)
Guotai Haitong Analyst forecast on ULIHF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$3
Buy
59.74%
Upside
Reiterated
07/10/25
TFI Asset Management Analyst forecast on ULIHF
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
$2.4
Buy
27.75%
Upside
Reiterated
05/20/25
Goldman Sachs Analyst forecast on ULIHF
Goldman Sachs
Goldman Sachs
$1.34$1.96
Hold
4.07%
Upside
Reiterated
03/26/25
United Laboratories Int'l Holdings Ltd. (3933:HK) (ULIHF) PT Raised to HK$15.29 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on United Laboratories Int'l Holdings Ltd. (3933:HK) (OTC: ULIHF) to HK$15.29 (from HK$10.50) while maintaining a Neutral rating.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
First Shanghai Securities Analyst forecast on ULIHF
Unknown Analyst
First Shanghai Securities
Not Ranked
First Shanghai Securities
$2.28
Buy
21.15%
Upside
Reiterated
11/10/25
The United Laboratories International Holdings (ULIHF) Gets a Buy from First Shanghai Securities
Morgan Stanley Analyst forecast on ULIHF
Unknown Analyst
Morgan Stanley
Not Ranked
Morgan Stanley
$1.7
Hold
-9.48%
Downside
Reiterated
09/19/25
Huatai Securities Analyst forecast on ULIHF
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$2.85
Buy
51.51%
Upside
Reiterated
09/06/25
Jefferies Analyst forecast on ULIHF
Jefferies
Jefferies
$2.18$2.56
Buy
36.13%
Upside
Reiterated
09/05/25
Jefferies Remains a Buy on The United Laboratories International Holdings (ULIHF)
Guotai Haitong Analyst forecast on ULIHF
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$3
Buy
59.74%
Upside
Reiterated
07/10/25
TFI Asset Management Analyst forecast on ULIHF
Unknown Analyst
TFI Asset Management
Not Ranked
TFI Asset Management
$2.4
Buy
27.75%
Upside
Reiterated
05/20/25
Goldman Sachs Analyst forecast on ULIHF
Goldman Sachs
Goldman Sachs
$1.34$1.96
Hold
4.07%
Upside
Reiterated
03/26/25
United Laboratories Int'l Holdings Ltd. (3933:HK) (ULIHF) PT Raised to HK$15.29 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on United Laboratories Int'l Holdings Ltd. (3933:HK) (OTC: ULIHF) to HK$15.29 (from HK$10.50) while maintaining a Neutral rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering The United Laboratories International Holdings

3 Months
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
-6.20%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -6.20% per trade.
1 Year
Success Rate
1/1 ratings generated profit
100%
Average Return
+2.50%
reiterated a buy rating 3 months ago
Copying xAi Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +2.50% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
-3.20%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -3.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ULIHF Analyst Recommendation Trends

Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
7
9
17
16
15
Buy
0
0
0
0
0
Hold
0
1
4
6
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
10
21
22
23
In the current month, ULIHF has received 15 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. ULIHF average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

ULIHF Stock Forecast FAQ

What is ULIHF’s average 12-month price target, according to analysts?
Currently, no data Available
What is ULIHF’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ULIHF, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is ULIHF a Buy, Sell or Hold?
      Currently, no data Available
      What is The United Laboratories International Holdings Limited’s price target?
      Currently, no data Available
      What do analysts say about The United Laboratories International Holdings Limited?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of ULIHF?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.